Sponsor Pipeline

Chengdu Kangnuoxing Biopharma,Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
6
Active Trials
1
Recruiting
2
Phase 3
1
Disease Areas
Active Trials by Phase
Phase 3
2
Phase 2
1
Not specified
3
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07210554 Study of Stapokibart Injection in Subjects With Moderate to Severe Bullous Pemphigoid Bullous Pemphigoid (BP) Not Yet Recruiting
NCT07678931 Study on the Treatment of Adolescent Patients With Seasonal Allergic Rhinitis Seasonal Allergic Rhinitis (SAR) Not Yet Recruiting
Phase 2
NCT07617324 Study of Stapokibart Injection in Adolescent Subjects With Seasonal Allergic Rhinitis… Seasonal Allergic Rhinitis (SAR) Not Yet Recruiting
Not specified
NCT07544862 A Study of Stapokibart Injection in Patients With Atopic Dermatitis (AD) Atopic Dermatitis (AD) Recruiting
NCT07459556 A Prospective Study of Stapokibart Injection in Patients With Seasonal Allergic Rhinitis… SAR Not Yet Recruiting
NCT07483268 A Study of Stapokibart Injection in Patients With Chronic Rhinosinusitis With Nasal… CRSWNP Active, Not Recruiting
Disease Areas
Atopic Dermatitis (1)
Get alerts when Chengdu Kangnuoxing Biopharma,Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free